Absorption variability may compound over months, leading to less predictable long-term outcomes
Implementing periodic washout phasessuch as 5 days on, 2 days off, or alternating weekspreserves receptor sensitivity while maintaining neuroplastic stimulus across extended protocols
LeungCMDe HaanPRonaldson-BouchardKKimGAKoJRhoHSet al
Records should include current weight, BMI, weight history, diagnoses, and relevant comorbid conditions
February 20, 2024: FDA warns companies selling unapproved semaglutide and tirzepatide Major Stories The U.S
Mounjaro (tirzepatide) is a GLP-1 receptor agonist that has transformed weight loss treatment for millions of patients, but its use raises important questions about blood and plasma donation eligibility